EU GMP Webinar
EU GMP: A Roadmap to Global Cannabis Selling
In recent times, Cannabis production has become one of the most prominent emerging industries in the world. Canada is the only country of the G7 that has legalized cannabis throughout its territory. With the legalization of cannabis, Canadian companies have turned their attention to the import and export of cannabis for medical purposes and for research globally.
With the evolving regulatory framework for Cannabis in countries other than Canada, it is often considered an Active Pharmaceutical Ingredient (API) and, as such, it is required that the facility be compliant with the European Union’s Good Manufacturing Practices (EU GMP). To cope up with the emerging needs Canadian producers need to comply with the regulatory steps that are required of an exporter in order to enter the European market.
Why do you need to get EU GMP certification and what is the necessary process for receiving EU GMP certification? Our expert is here to answer all your queries. To learn more about EU GMP, register for our complimentary webinar today!
About the Speaker:
Terry Pilkey has over 40 years of combined experience in the Pharmaceutical Industry including as a Regulator (7 years) and over the last 27 years as a Principal Auditor to the Pharmaceutical and Cannabis sector across the areas of regulatory, quality and compliance.
As the Regulatory Affairs Director for Eurofins BioPharma Product Testing Toronto Inc, Terry brings extensive industry experience spanning the areas of Regulatory Affairs, Quality Assurance, Quality Control and Regulatory Compliance.
This is a live webinar on September 20, 2021 - 12:00pm EST